熱門資訊> 正文

Culper Research的短期报告导致ADMA生物制品股价下跌

2026-03-25 02:44

ADMA Biologics (ADMA) fell 15% amid a short report from Culper Research.
Culper Research disclosed that it's short shares of ADMA Biologics (ADMA).
ADMA (ADMA) didn't immediately respond to Seeking Alpha's email request for comment.

More on ADMA Biologics

ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript
ADMA Biologics: Business Update And My Price Target
ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ADMA Biologics announces $125M accelerated share repurchase with JPmorgan
ADMA forecasts $635M revenue for 2026 as ASCENIV drives margin expansion and new supply deals extend growth runway

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。